ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 2: NeoplasmsD20

D20

Billable

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

Chapter 2:Neoplasms

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D20 is a billable code used to indicate a diagnosis of benign neoplasm of soft tissue of retroperitoneum and peritoneum.

Key Diagnostic Point:

Benign neoplasms of the soft tissue in the retroperitoneum and peritoneum are non-cancerous tumors that can arise from various types of soft tissue, including adipose tissue, fibrous tissue, and vascular tissue. These neoplasms may present as asymptomatic masses or cause symptoms depending on their size and location. Common types include lipomas, fibromas, and hemangiomas. Diagnosis typically involves imaging studies such as ultrasound, CT, or MRI, which help delineate the tumor's characteristics and its relationship to surrounding structures. Surgical excision is often the treatment of choice, especially if the neoplasm is symptomatic or growing. Follow-up care may include regular imaging to monitor for recurrence, particularly in cases where complete excision is not feasible. The prognosis for patients with benign neoplasms is generally favorable, with low rates of recurrence following appropriate management.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between benign and malignant neoplasms
  • Understanding the specific type of soft tissue involved
  • Variability in presentation and symptoms
  • Need for imaging studies to confirm diagnosis

Audit Risk Factors

  • Inadequate documentation of tumor characteristics
  • Failure to specify the location of the neoplasm
  • Misclassification of benign neoplasms as malignant
  • Lack of follow-up documentation post-surgery

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports and imaging studies must be included.

Common Clinical Scenarios

Patients presenting with abdominal masses requiring imaging and potential surgical intervention.

Billing Considerations

Ensure clear documentation of tumor type and treatment plan to avoid misclassification.

General Surgery

Documentation Requirements

Operative reports detailing the excision of neoplasms and any complications.

Common Clinical Scenarios

Surgical removal of benign tumors in the retroperitoneum or peritoneum.

Billing Considerations

Document the size, location, and histological type of the neoplasm for accurate coding.

Coding Guidelines

Inclusion Criteria

Use D20 When
  • Follow the official ICD
  • CM coding guidelines, ensuring to use D20 for benign neoplasms specifically located in the retroperitoneum and peritoneum

Exclusion Criteria

Do NOT use D20 When
  • Exclude malignant neoplasms and ensure accurate documentation of the tumor type

Related CPT Codes

49180CPT Code

Excision, retroperitoneal tumor

Clinical Scenario

Used when a benign neoplasm is surgically excised from the retroperitoneum.

Documentation Requirements

Operative report detailing the excision and pathology results.

Specialty Considerations

Ensure the surgical specialty is documented for accurate coding.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes.

Reimbursement & Billing Impact

reimbursement processes.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between benign and malignant neoplasms?

Benign neoplasms are non-cancerous growths that do not invade surrounding tissues or metastasize, while malignant neoplasms are cancerous and can spread to other parts of the body.